{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:02:48Z","timestamp":1776052968417,"version":"3.50.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Prostatic urothelial carcinoma is a rare disease. Medical misdiagnosis rates remain high because there are no specific clinical symptoms or imaging features, which decreases patient survival. We report a case of prostatic urethral cancer confirmed by transrectal ultrasound-guided prostate biopsy because of an abnormal digital rectal exam.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 55-year-old man was referred to our hospital due to lower urinary tract symptoms that lasted for 5 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses and Interventions:<\/jats:title>\n            <jats:p>On digital rectal examination, a hard and enlarged prostate was detected. Computed tomography, bone scintigraphy, and magnetic resonance imaging indicated benign prostatic hyperplasia. The patient underwent transrectal ultrasound-guided prostate biopsy. From the histopathological examination and immunohistochemical markers, a diagnosis of high-grade prostatic urothelial carcinoma was made. We excluded the possibility of urothelial cancer originating in the bladder lining after transurethral resection of the bladder. Radical cystoprostatectomy was performed, followed by 6 cycles of cisplatin and gemcitabine chemotherapy. Postoperative pathology showed primary urothelial carcinoma of the prostate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient recovered smoothly after surgery. After a 6-month follow-up, no evidence of local recurrence or metastatic disease was found.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case reminds clinicians that, for middle-aged men with suspicious digital rectal examinations, a diagnosis of prostatic urothelial carcinoma should be considered. Initial radical surgery followed by combination chemotherapy is suggested for therapeutic management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014155","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T03:06:45Z","timestamp":1547694405000},"page":"e14155","source":"Crossref","is-referenced-by-count":11,"title":["Primary urothelial carcinoma of the prostate"],"prefix":"10.1097","volume":"98","author":[{"given":"Jun","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Anhui Medical University"},{"name":"Institute of Urology and Anhui Province Key Laboratory of Genitourinary Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Anhui Medical University"},{"name":"Institute of Urology and Anhui Province Key Laboratory of Genitourinary Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxiang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Anhui Medical University"},{"name":"Institute of Urology and Anhui Province Key Laboratory of Genitourinary Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Anhui Medical University"},{"name":"Institute of Urology and Anhui Province Key Laboratory of Genitourinary Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Anhui Medical University"},{"name":"Department of Pathology, Anhui Medical University, Hefei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Tai","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Anhui Medical University"},{"name":"Institute of Urology and Anhui Province Key Laboratory of Genitourinary Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaozhao","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Anhui Medical University"},{"name":"Institute of Urology and Anhui Province Key Laboratory of Genitourinary Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0090-4295(84)90098-0","article-title":"Primary transitional cell carcinoma of prostate","volume":"24","author":"Nicolaisen","year":"1984","journal-title":"Urology"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/1097-0142(196909)24:3<543::AID-CNCR2820240317>3.0.CO;2-#","article-title":"Transitional cell carcinoma of the prostate","volume":"24","author":"Rubenstein","year":"1969","journal-title":"Cancer"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0022-5347(17)38047-3","article-title":"Transitional cell carcinoma of the prostate","volume":"146","author":"Matzkin","year":"1991","journal-title":"J Urol"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00000478-200106000-00012","article-title":"A clinicopathologic analysis of urothelial carcinomas diagnosed on prostate needle biopsy","volume":"25","author":"Oliai","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/PAS.0b013e31802f5d33","article-title":"Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma","volume":"31","author":"Chuang","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.humpath.2014.02.023","article-title":"Differential expression of GATA-3 in urothelial carcinoma variants","volume":"45","author":"Liang","year":"2014","journal-title":"Hum Pathol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<703::AID-CNCR13>3.0.CO;2-1","article-title":"Transitional cell carcinoma of the prostate: clinicopathologic study of 50 cases","volume":"82","author":"Cheville","year":"1998","journal-title":"Cancer"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/ajcp\/40.2.183","article-title":"Carcinoma originating in duets surrounding the prostatic urethra","volume":"40","author":"Ende","year":"1963","journal-title":"Am J Clin Pathol"},{"key":"R9-20230914","first-page":"242","article-title":"Urothelial carcinoma of the prostate","volume":"3","author":"Goebbels","year":"1985","journal-title":"Appl Pathol"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0022-5347(17)60451-8","article-title":"Intraduclal carcinoma of the prostate gland","volume":"109","author":"Rhamy","year":"1973","journal-title":"J Urol"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/1097-0142(197202)29:2<287::AID-CNCR2820290204>3.0.CO;2-Q","article-title":"Transitional cell carcinoma of the prostate. A clinical morphological study","volume":"29","author":"Johnson","year":"1972","journal-title":"Cancer"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1464-410X.1979.tb03605.x","article-title":"Transitional cell carcinoma of the prostate","volume":"51","author":"Kirk","year":"1979","journal-title":"Br J Urol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/modpathol.3880220","article-title":"Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma","volume":"13","author":"Genega","year":"2000","journal-title":"Mod Pathol"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0022-5347(05)66352-5","article-title":"The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer","volume":"165","author":"Donat","year":"2001","journal-title":"J Urol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1586\/14737140.7.3.383","article-title":"Urothelial carcinoma in the prostatic urethra and prostate. Current controversies","volume":"7","author":"Liedberg","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.urolonc.2007.12.010","article-title":"Dilemmas in the treatment of urothelial cancers of the prostate","volume":"27","author":"Walsh","year":"2009","journal-title":"Urol Oncol"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-5347(17)41031-7","article-title":"Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra","volume":"141","author":"Bretton","year":"1989","journal-title":"J Urol"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"e2572","DOI":"10.1097\/MD.0000000000002572","article-title":"Combination of intravesical chemotherapy and bacillus calmette-guerin versus bacillus calmette-guerin monotherapy in intermediate- and high-risk nonmuscle invasive bladder cancer: a systematic review and meta-analysis","volume":"95","author":"Cui","year":"2016","journal-title":"Medicine"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0022-5347(17)42389-5","article-title":"Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin","volume":"139","author":"Hillyard","year":"1988","journal-title":"J Urol"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0022-5347(01)66762-4","article-title":"The prostate involvement as prognostic factor in patients with superficial bladder cancer","volume":"154","author":"Solsona","year":"1995","journal-title":"J Urol"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eururo.2005.12.019","article-title":"Intravesical instillations with bacillus Calmette-Gu\u00e9rin for the treatment of carcinoma in situ involving prostatic ducts","volume":"49","author":"Palou Redorta","year":"2006","journal-title":"Eur Urol"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0090-4295(85)90481-9","article-title":"Primary transitional cell carcinoma of prostatic periurethral ducts","volume":"25","author":"Sawczuk","year":"1985","journal-title":"Urology"},{"issue":"(suppl 1)","key":"R23-20230914","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.urology.2006.05.059","article-title":"Urothelial carcinoma of the prostate","volume":"69","author":"Palou","year":"2007","journal-title":"Urology"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"2050312118783011","DOI":"10.1177\/2050312118783011","article-title":"Impact of relative dose intensity in gemcitabine-cisplatin chemotherapy for metastatic urothelial carcinoma","volume":"6","author":"Kohei","year":"2018","journal-title":"SAGE Open Med"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"e2297","DOI":"10.1097\/MD.0000000000002297","article-title":"Third-line chemotherapy for metastatic urothelial cancer: a retrospective observational study","volume":"94","author":"Di Lorenzo","year":"2015","journal-title":"Medicine"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1464-410X.1979.tb03605.x","article-title":"Transitional cell carcinoma of the prostate","volume":"51","author":"Kirk","year":"1979","journal-title":"Br J Urol"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1464-410X.1981.tb06099.x","article-title":"The management of transitional cell carcinoma in the prostate","volume":"53","author":"Wolfe","year":"1981","journal-title":"Br J Urol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201901180-00069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:33:07Z","timestamp":1694719987000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201901180-00069"}},"subtitle":["A rare case report"],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014155","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}